Alteration of Lipoprotein Profile during Total Parenteral Nutrition with Intralipid 10%

Abstract

Eight patients were studied for lipoprotein profiles over a period of 3-7 weeks. Four patients received total parenteral nutrition (TPN), including 1000 ml/day of Intralipid 10%. Three patients received fat-free TPN, and one patient was tube fed 1000 ml/day of Intralipid 10% enterally.

Fat-free TPN lowered plasma lipid, especially low density lipoprotein (LDL) and high density lipoproteins (HDL). On the other hand, intravenous administration of Intralipid 10% caused a marked increase of LDL, together with increases of phospholipid and cholesterol, especially free cholesterol. Triglyceride, VLDL, and HDL remained within the normal range in this group. Enteral administration of the same amount of Intralipid 10% did not cause a rise of LDL. Lipid composition of the increased LDL approximated that of lipoprotein X with the intravenous Intralipid 10%.

From these findings, we suggest that phospholipids in Intralipid 10% formed abnormal LDL as the result of mobilization of cholesterol from extravascular tissues, when administered intravenously. (Journal of Parenteral and Enteral Nutrition 10:622-626, 1986)

Get full access to this article

View all access options for this article.

References

Schuberth (O. : Clinical experience with fat emulsions for intravenous use. Acta Chir Scand [Suppl] 325:43-49. 1964

Kinsel LW Michaels GD , Imaichi K. : Studies with fat emulsions: Metabolism of intravenously administered 14C-tripalmitin . Am J Clin Nutr 16:97-100, 1965

Hallberg D. : Elimination of exogenous lipids from the blood stream. An experimental methodological and clinical study in dog and man. Acta Physiol Scand [Suppl] 254:2-22, 1965

Jeejeebhoy KN Marliss EB Anderson GH , et al: Lipid in parenteral nutrition: Studies of clinical and metabolic features. IN Fat Emulsion in Parenteral Nutrition, Meng HC , Wilmore DW (ed). American Medical Association . 1976, pp 45-54

Seidel D. , Alaupovic P. Furman RH : A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest 48:1211-1223. 1969

Chait A. Foster D. Miller DG , et al: Acceleration of low-density lipoprotein catabolism in man by total parenteral nutrition. Proc Soc Exp Biol Med 168:97-104, 1981

Friedman M. Byers SO : Role of hyperphospholipidemia and neutral fat increase in plasma in the pathogenesis of hypercholesteremia. Am J Physiol 186:13. 1956

Byers SO Friedman M. : Effect of infusions of phopshatides upon the atherosclerotic aorta in situ and as an occular aortic implant. J Lipid Res 1:343-348. 1960

Thompson GR Segura R. Hoff H. , et al: Contrasting effects on plasma lipoproteins of intravenous versus oral administration of a triglyceride-phospholipid emulsion. Eur J Clin Invest 5:373-384, 1975

10.

Thompson GR , Jadhav A. , Nava M. , et al: Effects of intravenous phospholipid on low density lipoprotein turnover in man. Eur J Clin Invest 6:241-248, 1976

11.

Breckenridge WC , Kakis G. , Kukis A. : Identification of lipoprotein X-like particles in rat plasma following intralipid infusion. Can J Biochem 57:72-82, 1979

12.

Untracht SH : Intravascular metabolism of an artificial transporter of triacylglycerols. Biochim Biophys Acta 711:176-192, 1982

13.

Burgess P. , Hall RI : Quantification of lipoprotein X and its relationship to plasma lipid profile during different types of parenteral nutrition. JPEN 9:377-378, 1985